🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 84833T103
- Market Cap
- Small Cap
- IPO
- 11/2/2017 · $$14.00/share
Business: Spero Therapeutics, Inc. is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug resistant bacterial infections.
Company Contact
- CEO
- Esther Rajavelu
- CFO
- Esther Rajavelu
- Headquarters
- 675 Massachusetts Avenue, 14th Floor, Cambridge, MA 02139
- Phone
- 857-242-1600
- Investor Relations
- Sharon Klahre · 857-242-1547 · ir@sperotherapeutics.com